FTSE MIB
33.922,16 +40,66 (+0,12%) Dow Jones
37.994,78 +219,40 (+0,58%) Nasdaq
15.389,21 -212,29 (-1,36%) Nikkei 225
37.068,35 -1.011,35 (-2,66%) Petrolio
83,50 +0,77 (+0,93%) Bitcoin EUR
60.189,41 +519,25 (+0,87%)
The Cooper Companies, Inc. (COO)
| Chiusura precedente | 90,41 |
| Aperto | 90,92 |
| Denaro | 90,42 x 200 |
| Lettera | 90,61 x 300 |
| Min-Max giorno | 90,34 - 90,99 |
| Intervallo di 52 settimane | 75,93 - 104,07 |
| Volume | |
| Media Volume | 1.127.464 |
| Capitalizzazione | 17,984B |
| Beta (5 anni mensile) | 0,95 |
| Rapporto PE (ttm) | 61,98 |
| EPS (ttm) | 1,46 |
| Prossima data utili | 30 mag 2024 |
| Rendimento e dividendo (futuro) | 0,02 (0,02%) |
| Data ex dividendo | 26 lug 2023 |
| Stima target 1A | 108,36 |
GlobeNewswireCooperCompanies Announces Transfer of Stock Exchange Listing to Nasdaq
SAN RAMON, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced that it will transfer the listing of its common stock from the New York Stock Exchange (“NYSE”) to the Nasdaq Stock Market (“Nasdaq”). Cooper expects to begin trading as a Nasdaq-listed company at market open on September 26, 2023, and will continue to trade under the symbol “COO.” “We are excited to join many of the world’s largest and most innovative companies on Nasdaq,” said Al White, President
- GlobeNewswire
CooperCompanies to Present at the Baird Healthcare Conference
SAN RAMON, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Baird Healthcare Conference on Wednesday, September 13, 2023. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a session scheduled to begin at 1:25 PM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com. A replay of the event will be a
- GlobeNewswire
CooperCompanies Announces Third Quarter 2023 Results
SAN RAMON, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal third quarter ended July 31, 2023. Revenue increased 10% year-over-year to $930.2 million. CooperVision (CVI) revenue up 11% to $630.2 million, and CooperSurgical (CSI) revenue up 8% to $300.0 million.GAAP diluted earnings per share (EPS) of $1.71, down $0.27 or 14% from last year's third quarter.Non-GAAP diluted EPS of $3.35, up $0.16 or 5% from last year's third qua
